Data & APIsEventsMarketfyPremarketBoost
Contribute Login Join
Data & APIs
Events
Marketfy
Premarket
Boost

John Patrick Shannon Jr's Net Worth

$5.48 Million

Estimate Recalculated Sep 8, 2024 07:30PM EST

Who is John Patrick Shannon Jr?

John Patrick Shannon Jr has an estimated net worth of $5.48 Million. This is based on reported shares across multiple companies, which include Xeris Biopharma Holdings, Inc., XERIS PHARMACEUTICALS INC, and Durata Therapeutics, Inc..

SEC CIK

John Patrick Shannon Jr's CIK is 0001553595

Past Insider Trading and Trends

2021 was John Patrick Shannon Jr's most active year for acquiring shares with 11 total transactions. John Patrick Shannon Jr's most active month to acquire stocks was the month of September. 2021 was John Patrick Shannon Jr's most active year for disposing of shares, totalling 8 transactions. John Patrick Shannon Jr's most active month to dispose stocks was the month of December. 2013 saw John Patrick Shannon Jr paying a total of $149,800.00 for 20,000 shares, this is the most they've acquired in one year. In 2024 John Patrick Shannon Jr cashed out on 173,734 shares for a total of $422,832.16, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Xeris Biopharma Holdings, Inc. (XERS) Snapshot price: $2.51

See Remarks

John Patrick Shannon Jr owns 2,148,061 units of Common Stock which is worth $5,391,633.11. In the year 2024 John Patrick Shannon Jr filed a total of 8 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-0.99%
-21.55K
$2.06
-$559,807.87
2.15M
Aug 2, 2024
Jan 29 - Aug 1
Form 4
+53.25%
750K
—
—
2.16M
Jan 31, 2024
Jan 31
Form 4
+2.23%
30.77K
$1.64
$50,399.62
1.41M
Nov 17, 2023
Nov 17
Form 4
+119.46%
750K
—
—
1.38M
Feb 1, 2023
Jan 31
Form 4
+67.77%
250K
—
—
618.91K
Jan 5, 2022
Jan 3
Form 4
+37.90%
100K
$2.10
$209,500.00
363.83K
Nov 12, 2021
Nov 11 - Nov 12
Form 4
∞
263.83K
—
—
263.83K
Oct 5, 2021
Oct 5
Form 3
—
0
—
—
0
Oct 5, 2021
No matching records found

XERIS PHARMACEUTICALS INC No price found

See Remarks

John Patrick Shannon Jr used to own units in Common Stock but no longer holds any shares there. In the year 2018 John Patrick Shannon Jr filed a total of 13 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-263.83K
—
—
0
Oct 5, 2021
Oct 5
Form 4
+123.74%
150K
—
—
271.22K
Feb 1, 2021
Jan 29
Form 4
—
0
—
—
0
Aug 20, 2020
Aug 18
Form 4
+3.18%
3.73K
$2.26
$8,432.06
121.22K
Jul 15, 2020
Jun 30
Form 4
+23.04%
22K
$3.55
$77,994.40
117.49K
May 14, 2020
May 13
Form 4
+9.00%
7.89K
$3.20
$25,219.43
95.49K
May 11, 2020
May 8
Form 4
+287.52%
65K
—
—
87.61K
Mar 2, 2020
Jan 31
Form 4
+114.10%
12.05K
$4.15
$49,999.20
22.61K
Feb 18, 2020
Feb 14
Form 4
+4.33%
438
$5.99
$2,623.62
10.56K
Jan 6, 2020
Dec 31
Form 4
+12.67%
1.14K
$9.72
$11,061.36
10.12K
Jul 3, 2019
Jul 1
Form 4
—
0
—
—
0
Feb 1, 2019
Jan 31
Form 4
∞
8.98K
—
—
8.98K
Jun 27, 2018
Jun 25
Form 3
—
0
—
—
0
Jun 20, 2018
No matching records found

Durata Therapeutics, Inc. No price found

Chief Commercial Officer

John Patrick Shannon Jr used to own units in Common Stock but no longer holds any shares there.acquired a total of 3,000 shares in Durata Therapeutics, Inc. at a cost of $41,160.00, John also disposed a total of 11,000 shares of Durata Therapeutics, Inc..

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-11.00K
—
—
0
Nov 18, 2014
Nov 17
Form 4
+37.50%
3K
$13.72
$41,160.00
11K
Aug 13, 2014
Aug 12
Form 4
—
0
—
—
0
May 22, 2014
May 21
Form 4
—
0
—
—
0
Feb 14, 2013
Feb 12
Form 3
—
0
—
—
0
Jul 18, 2012
No matching records found